Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM BICARBONATE

SODIUM BICARBONATE

Standard Dose
44.6MEQ/50ML (0.9MEQ/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SODIUM BICARBONATE is listed in Drugs@FDA under application 211091 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BICARBONATE Form and strength SOLUTION;INTRAVENOUS - 44.6MEQ/50ML (0.9MEQ/ML) Sponsor EXELA PHARMA Submission history Latest submission status date: 2019-06-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM BICARBONATE is listed in Drugs@FDA under application 211091 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BICARBONATE Form and strength SOLUTION;INTRAVENOUS - 44.6MEQ/50ML (0.9MEQ/ML) Sponsor EXELA PHARMA Submission history Latest submission status date: 2019-06-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.